| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -95 | -119 |
| Effect of exchange rate on cash and cash equivalents | -182 | -286 |
| Net decrease in cash and cash equivalents and restricted cash | -22,972 | -17,693 |
| Cash and cash equivalents at beginning of period | 52,935 | - |
| Cash and cash equivalents at end of period | 29,963 | - |
TELA Bio, Inc. (TELA)
TELA Bio, Inc. (TELA)